Explore the groundbreaking AI genomics platform, Inference, launched by Variant Bio to enhance drug discovery using genetic ...

Kiwi have started to hatch on Waiheke Island. They might start thriving with the help of special detection dogs helping ...

For decades, restoring sight after severe eye damage sat firmly in the realm of science fiction. Now a wave of converging ...

Across biology labs, the idea that aging might be governed by a few crucial switches is moving from science fiction to bench ...

Researchers have conducted the most comprehensive analysis to date linking plasma proteins to genetic variation in ...

Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.

Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013, calling it the biggest ...

A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...

Code Violet’s storyline is riddled with clichés typical of the science fiction genre. Set in a far-future space colony, the game attempts to blend themes of genetic modification and survival horror.

SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a novel approach to chronic pain management and joint tissue preservation.

The map was developed by using single-cell RNA sequencing to analyze 1.4 million plasma and immune cells in bone marrow from over 300 patients.

DNA doesn’t just sit still inside our cells — it folds, loops, and rearranges in ways that shape how genes behave.